The Hypothetical Impact of Accelerate Pheno on Time to Effective Therapy and Time to Definitive Therapy for Bloodstream Infections Due to Drug-Resistant Gram-Negative Bacilli | Zendy

Oryan Henig | Zendy; Keith S. Kaye | Zendy; Suganya Chandramohan | Zendy; Christopher Cooper | Zendy; Paul Lephart | Zendy; Hossein Salimnia | Zendy; Maureen Taylor | Zendy; Jason M. Pogue | Zendy

Open Access

The Hypothetical Impact of Accelerate Pheno on Time to Effective Therapy and Time to Definitive Therapy for Bloodstream Infections Due to Drug-Resistant Gram-Negative Bacilli

Author(s) -

Oryan Henig,

Keith S. Kaye,

Suganya Chandramohan,

Christopher Cooper,

Paul Lephart,

Hossein Salimnia,

Maureen Taylor,

Jason M. Pogue

Publication year - 2018

Publication title -

antimicrobial agents and chemotherapy

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.07

H-Index - 259

eISSN - 1070-6283

pISSN - 0066-4804

DOI - 10.1128/aac.01477-18

Subject(s) - gram , bloodstream infection , antimicrobial , pharmacotherapy , medicine , drug , drug resistance , combination therapy , multi drug resistant , intensive care medicine , microbiology and biotechnology , biology , bacteria , pharmacology , genetics

Strategies are needed to improve time to optimal therapy in patients with bloodstream infections (BSI) due to resistant Gram-negative (GN) pathogens. Accelerate Pheno (ACC) can provide antimicrobial susceptibility results within 7 h of a positive culture and may more rapidly optimize therapy.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research